Renal biopsy is viewed as the gold standard for diagnosis and management of many kidney diseases, especially glomerulopathies. However, the histopathological descriptions currently used in clinical practice often are neither diagnostic nor prognostic. The paper by Sethi et al. highlights the availability of a newer investigative tool that can be used to better define pathogenesis and, perhaps more important, to discover robust biomarkers of kidney disease cause and outcome
Introduction: Diabetic nephropathy (DN) and hypertensive nephrosclerosis (HN) represent the most com...
Background: Medullary sponge kidney (MSK) disease is a rare and neglected congenital condition typic...
The past decade has resulted in multiple new findings of potential proteomic biomarkers of diabetic ...
Renal biopsy is viewed as the gold standard for diagnosis and management of many kidney diseases, es...
Proteomics is a rapidly advancing technique which gives a functional insight into gene expression in...
In this article, the benefits of urinary proteomics in comparison with kidney biopsy are discussed. ...
Kidney disease is one of the fastest growing causes of death worldwide, disclosing an unmet clinical...
Proteomics is a rapidly advancing technique which gives functional insight into gene expression in l...
Abstract Renal diseases are prevalent and important. However, despite significant stri...
Purpose of review: Urine is the most useful of body fluids for biomarker research. Therefore, we hav...
INTRODUCTION: Chronic kidney disease (CKD) is a worldwide public health problem, related to increase...
Hypertensive nephropathy (HN) requires a kidney biopsy as diagnostic gold-standard but histological ...
Background: The contrast between a high prevalence of chronic kidney disease (CKD) and the low incid...
Renal diseases are driven by alterations in the entity of proteins within the kidney, at the level o...
Background: In spite of its invasive nature and risks, kidney biopsy is currently required for preci...
Introduction: Diabetic nephropathy (DN) and hypertensive nephrosclerosis (HN) represent the most com...
Background: Medullary sponge kidney (MSK) disease is a rare and neglected congenital condition typic...
The past decade has resulted in multiple new findings of potential proteomic biomarkers of diabetic ...
Renal biopsy is viewed as the gold standard for diagnosis and management of many kidney diseases, es...
Proteomics is a rapidly advancing technique which gives a functional insight into gene expression in...
In this article, the benefits of urinary proteomics in comparison with kidney biopsy are discussed. ...
Kidney disease is one of the fastest growing causes of death worldwide, disclosing an unmet clinical...
Proteomics is a rapidly advancing technique which gives functional insight into gene expression in l...
Abstract Renal diseases are prevalent and important. However, despite significant stri...
Purpose of review: Urine is the most useful of body fluids for biomarker research. Therefore, we hav...
INTRODUCTION: Chronic kidney disease (CKD) is a worldwide public health problem, related to increase...
Hypertensive nephropathy (HN) requires a kidney biopsy as diagnostic gold-standard but histological ...
Background: The contrast between a high prevalence of chronic kidney disease (CKD) and the low incid...
Renal diseases are driven by alterations in the entity of proteins within the kidney, at the level o...
Background: In spite of its invasive nature and risks, kidney biopsy is currently required for preci...
Introduction: Diabetic nephropathy (DN) and hypertensive nephrosclerosis (HN) represent the most com...
Background: Medullary sponge kidney (MSK) disease is a rare and neglected congenital condition typic...
The past decade has resulted in multiple new findings of potential proteomic biomarkers of diabetic ...